Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now KOSDAQ - Delayed Quote • KRW 358570.KS,0P0001QOXH,881808 (358570.KS) Follow 12,200.00 -40.00 (-0.33%) At close: July 20 at 5:00:00 AM GMT+9 All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations GI Innovation-LaNova Medicines Signs MOU for GI-102 + ADC Pancreatic Cancer Combination Therapy GI Innovation (KQ:358570) announced that it signed a Memorandum of Understanding (MOU) with LaNova Medicines (LaNova) for the development of GI-102 and ADC pancreatic cancer combination therapy.